Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating pharmacokinetics and pharmacodynamics of different Δ9-THC formulations for nausea, vomiting, and cancer-related pain in chemotherapy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Pain
• Nausea and Vomiting Associated with Chemotherapy
• Neoplasms

Drugs mentioned

• Delta-9-tetrahydrocannabinol formulations (delta-9-tetrahydrocannabinol)

Snippet

Sponsor: LaSanta S A S | Conditions: Nausea Post Chemotherapy, Vomiting | Phase 1, Phase 2 | Status: UNKNOWN